交易 CureVac N.V. - CVAC CFD
加入收藏夹- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
交易條件
价差 | 0.06 | ||||||||
多头隔夜费
多头隔夜费
前往平台 | -0.026179% | ||||||||
空头隔夜费
空头隔夜费
前往平台 | 0.003957% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 5% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
CureVac NV ESG Risk Ratings
High Medium Low Negligible
“D”分數表示相對 ESG 表現較差,公開報告重要 ESG 數據的透明度不足。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Mar 28, 2024 | 3.00 | -0.03 | -0.99% | 3.03 | 3.16 | 2.98 |
Mar 27, 2024 | 3.02 | 0.06 | 2.03% | 2.96 | 3.05 | 2.87 |
Mar 26, 2024 | 2.92 | -0.19 | -6.11% | 3.11 | 3.23 | 2.87 |
Mar 25, 2024 | 3.12 | 0.14 | 4.70% | 2.98 | 3.16 | 2.98 |
Mar 22, 2024 | 3.02 | 0.03 | 1.00% | 2.99 | 3.10 | 2.97 |
Mar 21, 2024 | 3.00 | 0.08 | 2.74% | 2.92 | 3.06 | 2.91 |
Mar 20, 2024 | 3.02 | 0.25 | 9.03% | 2.77 | 3.02 | 2.73 |
Mar 19, 2024 | 2.90 | -0.21 | -6.75% | 3.11 | 3.18 | 2.90 |
Mar 18, 2024 | 3.18 | -0.05 | -1.55% | 3.23 | 3.26 | 3.16 |
Mar 15, 2024 | 3.27 | 0.02 | 0.62% | 3.25 | 3.32 | 3.23 |
Mar 14, 2024 | 3.31 | 0.02 | 0.61% | 3.29 | 3.34 | 3.22 |
Mar 13, 2024 | 3.33 | 0.04 | 1.22% | 3.29 | 3.48 | 3.29 |
Mar 12, 2024 | 3.37 | -0.01 | -0.30% | 3.38 | 3.45 | 3.24 |
Mar 11, 2024 | 3.33 | -0.07 | -2.06% | 3.40 | 3.56 | 3.29 |
Mar 8, 2024 | 3.40 | 0.12 | 3.66% | 3.28 | 3.48 | 3.28 |
Mar 7, 2024 | 3.29 | 0.04 | 1.23% | 3.25 | 3.32 | 3.23 |
Mar 6, 2024 | 3.25 | 0.01 | 0.31% | 3.24 | 3.32 | 3.24 |
Mar 5, 2024 | 3.30 | 0.04 | 1.23% | 3.26 | 3.34 | 3.24 |
Mar 4, 2024 | 3.35 | -0.03 | -0.89% | 3.38 | 3.40 | 3.23 |
Mar 1, 2024 | 3.39 | 0.05 | 1.50% | 3.34 | 3.50 | 3.34 |
CureVac N.V. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Tuesday, April 23, 2024 | ||
时间(协调世界时) (UTC) 06:30 | 国家 US
| 事件 Q4 2023 CureVac NV Earnings Release Q4 2023 CureVac NV Earnings ReleaseForecast(预报) -上一页 - |
Tuesday, May 21, 2024 | ||
时间(协调世界时) (UTC) 10:59 | 国家 US
| 事件 Q1 2024 CureVac NV Earnings Release Q1 2024 CureVac NV Earnings ReleaseForecast(预报) -上一页 - |
Tuesday, June 18, 2024 | ||
时间(协调世界时) (UTC) 12:00 | 国家 US
| 事件 CureVac NV Annual Shareholders Meeting CureVac NV Annual Shareholders MeetingForecast(预报) -上一页 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 67.42 | 102.99 | 48.871 | 17.416 | 12.871 |
收入 | 67.42 | 102.99 | 48.871 | 17.416 | 12.871 |
收入成本,共計 | 159.045 | 238.195 | 14.173 | 27.983 | 17.744 |
毛利 | -91.625 | -135.205 | 34.698 | -10.567 | -4.873 |
總營業費用 | 316.877 | 515.253 | 158.686 | 116.914 | 85.695 |
銷售/一般/行政費用,總計 | 95.264 | 93.164 | 48.169 | 48.367 | 24.644 |
研究與開發 | 53.9 | 811.648 | 111.23 | 42.768 | 40.579 |
Depreciation / Amortization | 20.346 | 13.24 | 8.696 | 2.831 | 2.873 |
Other Operating Expenses, Total | -36.186 | -574.6 | -23.582 | -5.035 | -0.145 |
營業收入 | -249.457 | -412.263 | -109.815 | -99.498 | -72.824 |
利息收入(費用),非經營淨值 | 0.302 | -0.235 | -20.033 | -0.627 | 1.693 |
稅前淨收入 | -249.155 | -412.498 | -129.848 | -100.125 | -71.131 |
稅後淨收入 | -249.029 | -411.716 | -129.122 | -99.873 | -71.241 |
未計算非常項目前的淨收益 | -249.029 | -411.716 | -129.122 | -99.873 | -71.241 |
淨收入 | -249.029 | -411.716 | -129.122 | -99.873 | -71.241 |
普通股股東可獲收益 (不含非經常性項目) | -249.029 | -411.716 | -129.122 | -99.873 | -71.241 |
普通股股東可獲收益 (含非經常性項目) | -249.029 | -411.716 | -129.122 | -99.873 | -71.241 |
攤薄淨收入 | -249.029 | -411.716 | -129.122 | -99.873 | -71.241 |
攤薄後加權平均股 | 194.997 | 187.121 | 180.461 | 176.46 | 176.46 |
扣除特別項目的每股攤薄盈利 | -1.27709 | -2.20027 | -0.71551 | -0.56598 | -0.40372 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | -1.17342 | -2.35167 | -0.71551 | -0.56598 | -0.40372 |
異常費用(收入) | 24.508 | -66.394 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 7.579 | 7.129 | 11.689 | 11.212 | 20.146 |
收入 | 7.579 | 7.129 | 11.689 | 11.212 | 20.146 |
收入成本,共計 | 25.855 | 20.634 | 80.001 | 24.079 | 42.681 |
毛利 | -18.276 | -13.505 | -68.312 | -12.867 | -22.535 |
總營業費用 | 79.381 | 67.484 | 133.199 | 63.592 | 80.445 |
銷售/一般/行政費用,總計 | 20.682 | 21.005 | 24.937 | 23.988 | 24.492 |
研究與開發 | 29.084 | 22.526 | 22.832 | 10.765 | 10.53 |
Depreciation / Amortization | 4.754 | 4.831 | 6.998 | 5.106 | 4.274 |
異常費用(收入) | -0.413 | -0.31 | -0.063 | -0.273 | -0.035 |
Other Operating Expenses, Total | -0.581 | -1.202 | -1.506 | -0.073 | -1.497 |
營業收入 | -71.802 | -60.355 | -121.51 | -52.38 | -60.299 |
利息收入(費用),非經營淨值 | 4.414 | 2.937 | -7.24 | 4.734 | 2.729 |
稅前淨收入 | -67.388 | -57.418 | -128.75 | -47.646 | -57.57 |
稅後淨收入 | -67.414 | -57.419 | -128.784 | -47.568 | -57.584 |
未計算非常項目前的淨收益 | -67.414 | -57.419 | -128.784 | -47.568 | -57.584 |
淨收入 | -67.414 | -57.419 | -128.784 | -47.568 | -57.584 |
普通股股東可獲收益 (不含非經常性項目) | -67.414 | -57.419 | -128.784 | -47.568 | -57.584 |
普通股股東可獲收益 (含非經常性項目) | -67.414 | -57.419 | -128.784 | -47.568 | -57.584 |
攤薄淨收入 | -67.414 | -57.419 | -128.784 | -47.568 | -57.584 |
攤薄後加權平均股 | 223.883 | 212.663 | 216.34 | 189.565 | 187.052 |
扣除特別項目的每股攤薄盈利 | -0.30111 | -0.27 | -0.59529 | -0.25093 | -0.30785 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.30231 | -0.27095 | -0.59547 | -0.25187 | -0.30797 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 584.029 | 940.019 | 1389.85 | 57.175 | 73.07 |
現金和短期投資 | 497.733 | 813.4 | 1323.02 | 31.114 | 60.404 |
現金等價物 | 495.797 | 811.464 | 1322.59 | 30.684 | 21.38 |
短期投資 | 1.936 | 1.936 | 0.43 | 0.43 | 39.024 |
應收賬款總額,淨額 | 11.553 | 21.216 | 4.011 | 18.714 | 8.848 |
應收賬款 - 貿易,淨額 | 9.002 | 18.504 | 1.822 | 17.153 | 6.858 |
總庫存 | 23.989 | 56.159 | 14.531 | 6.197 | 2.951 |
預付的費用 | 4.507 | 5.724 | 40.054 | 1.15 | 0.421 |
其他流動資産,總計 | 46.247 | 43.52 | 8.235 | 0.446 | |
總資産 | 860.472 | 1158.24 | 1511.36 | 130.62 | 125.659 |
物業/廠房/設備,總計 - 淨額 | 241.702 | 200.393 | 100.589 | 61.686 | 40.472 |
物業/廠房/設備,總計 - 總額 | 271.27 | 247.412 | 145.054 | 84.931 | 58.497 |
累計折舊,總計 | -29.568 | -47.019 | -44.466 | -23.245 | -18.025 |
無形資産,淨額 | 19.315 | 13.238 | 14.146 | 5.698 | 6.213 |
應收票據 - 長期 | 0.302 | 1.08 | 1.034 | 0.966 | 0.749 |
其他長期資産,總計 | 2.661 | 3.512 | 5.733 | 5.095 | 5.155 |
流動負債總額 | 156.225 | 357.734 | 247.622 | 28.086 | 28.13 |
應付賬款 | 73.463 | 127.703 | 21.685 | 5.331 | 9.029 |
預提費用 | 39.289 | 46.802 | 50.022 | 12.068 | 12.258 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 4.98 | 3.469 | 3.234 | 2.004 | 0.077 |
其他流動負債,總計 | 38.493 | 179.76 | 172.681 | 8.683 | 6.766 |
負債總額 | 327.219 | 469.766 | 800.009 | 173.422 | 93.576 |
長期債務總額 | 37.106 | 25.423 | 52.042 | 77.144 | 0 |
長期債務 | 0 | 25.189 | 65.018 | 0 | |
資本租賃義務 | 37.106 | 25.423 | 26.853 | 12.126 | 0 |
遞延所得稅 | 0 | 1.623 | 0 | ||
其他負債,總計 | 133.888 | 86.609 | 500.345 | 66.569 | 65.446 |
總權益 | 533.253 | 688.476 | 711.347 | -42.802 | 32.083 |
普通股 | 23.4 | 22.454 | 21.655 | 0.727 | 0.727 |
留存收益(累計赤字) | 511.473 | 671.873 | 689.635 | -43.551 | 31.366 |
其他權益,總計 | -0.139 | -0.034 | 0.057 | 0.022 | -0.01 |
總負債和股東權益 | 860.472 | 1158.24 | 1511.36 | 130.62 | 125.659 |
已發行普通股總數 | 194.958 | 187.121 | 180.461 | 176.46 | 176.46 |
Treasury Stock - Common | -1.481 | -5.817 | |||
商譽,淨額 | 12.463 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 536.833 | 603.21 | 686.916 | 584.029 | 622.282 |
現金和短期投資 | 467.6 | 543.279 | 620.588 | 500.284 | 543.464 |
現金等價物 | 464.145 | 537.925 | 617.519 | 495.797 | 540.865 |
短期投資 | 3.455 | 5.354 | 3.069 | 4.487 | 2.599 |
應收賬款總額,淨額 | 10.594 | 6.562 | 5.843 | 9.002 | 6.17 |
應收賬款 - 貿易,淨額 | 10.594 | 6.562 | 5.843 | 9.002 | 6.17 |
總庫存 | 23.3 | 22.194 | 24.678 | 23.989 | 7.868 |
預付的費用 | 25.453 | 21.221 | 25.597 | 40.287 | 60.952 |
其他流動資産,總計 | 9.886 | 9.954 | 10.21 | 10.467 | 3.828 |
總資産 | 842.566 | 899.48 | 973.672 | 860.472 | 910.512 |
物業/廠房/設備,總計 - 淨額 | 272.217 | 261.57 | 253.163 | 241.702 | 251.461 |
無形資産,淨額 | 30.469 | 31.7 | 30.6 | 31.778 | 33.775 |
其他長期資産,總計 | 3.047 | 3 | 2.993 | 2.963 | 2.994 |
流動負債總額 | 150.679 | 156.276 | 90.298 | 156.225 | 172.352 |
Payable/Accrued | 12.57 | 13.419 | 14.973 | 73.463 | 52.608 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 5.534 | 5.205 | 5.058 | 4.98 | 4.652 |
其他流動負債,總計 | 132.575 | 137.652 | 70.267 | 77.782 | 115.092 |
負債總額 | 240.301 | 250.433 | 260.273 | 327.219 | 285.524 |
長期債務總額 | 36.58 | 35.276 | 36.087 | 37.106 | 36.609 |
長期債務 | |||||
資本租賃義務 | 36.58 | 35.276 | 36.087 | 37.106 | 36.609 |
其他負債,總計 | 53.042 | 58.881 | 133.888 | 133.888 | 76.563 |
總權益 | 602.265 | 649.047 | 713.399 | 533.253 | 624.988 |
普通股 | 26.871 | 26.866 | 26.862 | 23.4 | 22.834 |
留存收益(累計赤字) | 575.547 | 622.304 | 687.001 | 511.473 | 604.286 |
Treasury Stock - Common | 0 | 0 | -0.344 | -1.481 | -1.734 |
其他權益,總計 | -0.153 | -0.123 | -0.12 | -0.139 | -0.398 |
總負債和股東權益 | 842.566 | 899.48 | 973.672 | 860.472 | 910.512 |
已發行普通股總數 | 223.924 | 223.873 | 223.819 | 194.958 | 190.244 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -249.155 | -412.498 | -129.848 | -100.125 | -71.131 |
经营活动产生的现金 | -286.177 | -733.128 | 522.403 | -86.963 | -74.11 |
经营活动产生的现金 | 23.741 | 15.674 | 10.671 | 7.164 | 3.781 |
非现金物品 | 67.744 | -350.082 | 40.194 | 20.432 | -5.889 |
Cash Taxes Paid | 0.128 | 0.502 | 0.093 | 0.345 | 0.026 |
营运资金的变化 | -128.511 | 15.361 | 602.482 | -14.434 | -0.871 |
投资活动产生的现金 | -93.499 | -127.901 | -45.274 | 28.181 | -4.264 |
资本支出 | -93.222 | -127.901 | -47.352 | -12.224 | -14.723 |
其他投资现金流量项目,总计 | -0.277 | 0 | 2.078 | 40.405 | 10.459 |
融资活动产生的现金 | 63.173 | 344.964 | 819.833 | 67.979 | -0.112 |
债务的发行(退还),净额 | -4.221 | -28.183 | -47.884 | 67.979 | -0.112 |
外汇效应 | 0.836 | 4.936 | -5.053 | 0.107 | 0.213 |
现金净变化 | -315.667 | -511.129 | 1291.91 | 9.304 | -78.273 |
已付现金利息 | 4.606 | 9.785 | 8.694 | 0.824 | |
Deferred Taxes | 0.004 | -1.583 | -1.096 | ||
股票的发行(报废),净额 | 0.91 | 373.147 | 867.717 | ||
融资现金流项目 | 66.484 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -57.418 | -249.155 | -120.405 | -72.759 | -15.189 |
Cash From Operating Activities | -99.586 | -286.177 | -237.091 | -201.175 | -136.511 |
Cash From Operating Activities | 5.853 | 23.741 | 23.349 | 16.651 | 9.077 |
Deferred Taxes | 0.002 | 0.004 | 0.049 | -0.01 | |
Non-Cash Items | -0.347 | 67.744 | -14.466 | -20.765 | -13.72 |
Cash Taxes Paid | 0.004 | 0.128 | 0.152 | 0.126 | |
Cash Interest Paid | 0.633 | 4.606 | 3.326 | 2.608 | 1.33 |
Changes in Working Capital | -47.676 | -128.511 | -125.618 | -124.292 | -116.679 |
Cash From Investing Activities | -13.162 | -93.499 | -72.559 | -44.715 | -17.185 |
Capital Expenditures | -13.162 | -93.222 | -72.559 | -44.715 | -17.185 |
Other Investing Cash Flow Items, Total | -0.277 | ||||
Cash From Financing Activities | 234.709 | 63.173 | 29.873 | 3.409 | -0.46 |
Issuance (Retirement) of Stock, Net | 235.969 | 0.91 | 0.635 | 0.631 | 0.44 |
Issuance (Retirement) of Debt, Net | -1.26 | -4.221 | -3.087 | -1.943 | -0.9 |
Foreign Exchange Effects | -0.239 | 0.836 | 9.178 | 4.583 | 0.895 |
Net Change in Cash | 121.722 | -315.667 | -270.599 | -237.898 | -153.261 |
Financing Cash Flow Items | 66.484 | 32.325 | 4.721 |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
CureVac N.V. Company profile
关于 CureVac BV
CureVac AG是一家位于德国的生物技术公司。 该公司从事信使核糖核酸(mRNA)和基于RNA的疫苗的治疗性开发。 CureVac AG专注于开发传染病疫苗和治疗癌症和罕见疾病的药物。 公司的管线集中在三个领域:癌症免疫疗法、预防疫苗和基于蛋白质的疗法。
Industry: | Biotechnology & Medical Research (NEC) |
Friedrich-Miescher-Str. 15
TUEBINGEN
BADEN-WUERTTEMBERG 72076
DE
收入報表
- Annual
- Quarterly
人們也觀看
还在找一位您可以信任的经纪商吗?
加入成为全球580,000万多名交易者的一份子,选择利用Capital.com进行交易吧。